Epstein Secrets

nding the largest round of funding yet to a CRISPR-Cas9 startup. Cambridge-based Editas Medicine is announcing a $120 million Series B round led by Bill Gates's chief advisor for science and technology, Boris Nikolic. The list of financiers teaming with Nikolic reads like a rolodex of so-called crossover in

s, and corporate venture arms. Among them: Deerfield Management, Viking Global Investors, Fidelity Management & Research, T. Rowe Price Associates, Google Ventures, Jennison Associates, Khosla Ventures, EcoR1 Capital, Casdin Capital, Omega Funds, Cowen Private Investments, and Alexandria Venture Investments. E

liputian Systems, and $33 million for EcoMotors, a developer of opposed-piston diesel engines, in a round led by Braemar Energy Ventures, along with Bill Gates Page 13 of 4 EFTA00598428 and Khosla Ventures. Transonic Combustion won $32 million and $31 million went to Solix for algal biofuel production.

12: Soladigm raised $55 million from Khosla and DBL Ventures for its electrochromic windows. Climate Corp. won $50 million from Khosla Ventures and Google Ventures. Coulomb Technologies raised $48 million from Kleiner and Siemens. A total of $41 million went to Genomatica, $40 million to Lilliputian Systems, an

invested in or know; Breakthrough Life Sciences Prize recipients; DST technology investment team, and; entities associated with our anchor investor Bill Gates, such as Bill Gates Ventures and the Bill and Melinda Gates Foundation. We are in the process of entering into an agreement with illumine, the leadi

ted revenue of S29m. In December 2012, the Principals invested Slim at a valuation of 5204m. Other investors in the round included Kleiner Perkins, Google Ventures, Roche and Labcorp. In September 2013, J.P. Morgan and Goldman Sachs led the IPO of Foundation Medicine. As of 240, January 2014, Foundation Medici